Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Subbiah Pugazhenthi to Enzyme Inhibitors

This is a "connection" page, showing publications Subbiah Pugazhenthi has written about Enzyme Inhibitors.

 
Connection Strength
 
 
 
0.232
 
  1. Vaishnav D, Jambal P, Reusch JE, Pugazhenthi S. SP600125, an inhibitor of c-jun N-terminal kinase, activates CREB by a p38 MAPK-mediated pathway. Biochem Biophys Res Commun. 2003 Aug 08; 307(4):855-60.
    View in: PubMed
    Score: 0.176
  2. Pugazhenthi S, Tanha F, Dahl B, Khandelwal RL. Inhibition of a Src homology 2 domain containing protein tyrosine phosphatase by vanadate in the primary culture of hepatocytes. Arch Biochem Biophys. 1996 Nov 15; 335(2):273-82.
    View in: PubMed
    Score: 0.028
  3. Son KN, Pugazhenthi S, Lipton HL. Activation of tumor suppressor protein p53 is required for Theiler's murine encephalomyelitis virus-induced apoptosis in M1-D macrophages. J Virol. 2009 Oct; 83(20):10770-7.
    View in: PubMed
    Score: 0.017
  4. Sze CI, Su M, Pugazhenthi S, Jambal P, Hsu LJ, Heath J, Schultz L, Chang NS. Down-regulation of WW domain-containing oxidoreductase induces Tau phosphorylation in vitro. A potential role in Alzheimer's disease. J Biol Chem. 2004 Jul 16; 279(29):30498-506.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)